Scholars Central

Research articlePublished 2021

MIXED IPV-OPV SCHEDULING TO HELP ERADICATE VACCINE-ASSOCIATED PARALYTIC POLIOMYELITIS

Authors: Dr Fazal-e-Rabi Subhani, Dr. Ahmad Ehsan Rabani, Dr. Fazal-i-Akbar Danish

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The In current OPV-using countries, an estimated 306-490 VAPP cases have been reported. The overall risk is about 1 case per 900,000 vaccines. This risk is exuberantly high (2 per 1000 vaccines) in individuals with B-cell immunodeficiency (OPV is thus contraindicated in immunodeficient individuals). Normal OPV recipient infants continue to shed OPV viruses for as long as 6-8 weeks after administration. In endemic places with inadequate vaccine coverage, the OPV viruses may consequently start to spread in the community.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Health Science Journal.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalHealth Science Journal
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Dr Fazal-e-Rabi Subhani”
  • BylineArticles whose byline prints “Dr. Ahmad Ehsan Rabani”
  • BylineArticles whose byline prints “Dr. Fazal-i-Akbar Danish”